(Q73916900)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11368431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11368431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11368431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

M Malec

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11368431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

E Björklund

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11368431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S Söderhäll

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11368431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A M Sjögren

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11368431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

P Pisa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11368431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Björkholm

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11368431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A Porwit-MacDonald

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11368431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 May 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11368431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11368431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11368431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11368431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

716-727

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11368431%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402091

7 November 2019

exact match

0 references

cites work

Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

Minimal residula disease status as a predictor of relapse after allogenic bone marrow transplantation for children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

Measurement of Residual Leukemia during Remission in Childhood Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

Multidimensional flow cytometry of marrow can differentiate leukemic from normal lymphoblasts and myeloblasts after chemotherapy and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

Multiparameter phenotype mapping of normal and post-chemotherapy B lymphopoiesis in pediatric bone marrow.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

Quantitative flow cytometry can distinguish between normal and leukaemic B-cell precursors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

Leukemia-associated changes identified by quantitative flow cytometry: I. CD10 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

Triple immunofluorescence staining for prediction of relapse in childhood precursor B acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

Minimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021

Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402091

7 January 2021